References
- Barstad B, Tveitnes D, Dalen I, et al. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis; associations with clinical and laboratory variables. Infect Dis. DOI:10.1080/23744235.2019.1671988
- Branda JA, Strle K, Nigrovic LE, et al. Evaluation of modified 2-tiered serodiagnostic testing algorithms for early Lyme disease. Clin Infect Dis. 2017;64(8):1074–1080.
- Lipsett SC, Branda JA, Nigrovic LE. Evaluation of the modified two-tiered testing (MTTT) method for the diagnosis of Lyme disease in children. J Clin Microbiol. 2019;57(10):e00547-19. DOI:10.1128/JCM.00547-19.
- Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6(1):42.
- Sillanpää H, Skogman BH, Sarvas H, et al. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis. 2013;45(7):526–530.